A Common Polymorphism of the Protein Z Gene Is Associated with Protein Z Plasma Levels and with Risk of Cerebral Ischemia in the Young

Stroke

Volumn 35, Issue 1, 2004, Pages 40-45

  Lichy, Christop ^a   Kropp, S ^b   Dong Si, T ^a   Genius, J ^a   Dolan, T ^a   Hampe, T ^a   Stoll, F ^a   Reuner, K ^c   Grond Ginsbach, C ^a   Grau, A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Deut Krebsforsch Ztr Heidelberg ^*  (Germany)

^c STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

Author keywords

Cerebral ischemia; Polymorphism; Protein Z

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; GERMANY; HUMAN; INTRON; JUVENILE STROKE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; RISK; STROKE; THROMBOSIS;

ADULT; BLOOD PROTEINS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; FACTOR V; FEMALE; GENE FREQUENCY; GERMANY; HUMANS; INTRONS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROMOTER REGIONS (GENETICS); PROTHROMBIN; RISK ASSESSMENT; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS);

EID: 9144258392     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000106909.75418.E4     Document Type: Article

References (24)

1. Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost. 2001;86:8-13.
2. Kemkes-Matthes B, Matthes KJ. Protein Z. Semin Thromb Hemost. 2001; 27:551-556.
3. Hogg PJ, Stenflo J. Interaction of vitamin K-dependent protein Z with thrombin: consequences for the amidolytic activity of thrombin and the interaction of thrombin with phospholipid vesicles. J Biol Chem. 1991; 266:10953-10958.
4. Kemkes-Matthes B, Matthes KJ. Protein Z deficiency: a new cause of bleeding tendency. Thromb Res. 1995;79:49-55.
5. Broze GJ Jr. Protein-Z and thrombosis. Lancet. 2001;357:900-901.
6. Ravi S, Mauron T, Lammle B, Wuillemin WA. Protein Z in healthy human individuals and in patients with a bleeding tendency. Br J Haematol. 1998;102:1219-1223.
7. Gamba G, Bertolino G, Montani N, Spedini P, Balduini CL. Bleeding tendency of unknown origin and protein Z levels. Thromb Res. 1998;90: 291-295.
8. Kemkes-Matthes B, Nees M, Kuhnel G, Matzdorff A, Matthes K. Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res. 2002;106:183.
9. Gris JC, Quere I, Dechaud H, Mercier E, Pincon C, Hoffet M, Vasse M, Mares P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood. 2002;99:2606-2608.
10. Greten J, Kreis I, Liliensiek B, et al. Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa. 1998;27:144-148.
11. Kobelt K, Biasiutti FD, Mattle HP, Lammle B, Wuillemin WA, Protein Z in ischaemic stroke. Br J Haematol. 2001;114:169-173.
12. Vasse M, Guegan-Massardier E, Borg JY, Woimant F, Soria C. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet. 2001;357:933-934.
13. Heeb MJ, Paganini-Hill A, Griffin JH, Fisher M. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis. 2002;29:139-144.
14. Hankey GJ, McQuillan A, Eikelboom J, Thom J, Baker R, Staton J, Cole V, Yi Quilong. Protein Z in ischemic stroke and its etiological subtypes. Stroke. 2003;34:292. Abstract.
15. Lopaciuk S, Bykowska K, Kwiecinski H. Czlonkowska A, Kuczynska-Zardzewialy A. Protein Z in young survivors of ischemic stroke. Thromb Haemost. 2002;88:536.
16. Fujimaki K, Yamazaki T, Taniwaki M, Ichinose A. The gene for human protein Z is localized to chromosome 13 at band q34 and is coded by eight regular exons and one alternative exon. Biochemistry. 1998;37: 6838-6846.
17. Rice GI, Futers TS, Grant PJ. Identification of novel polymorphisms within the protein Z gene, haplotype distribution and linkage analysis. Thromb Haemost. 2001;85:1123-1124.
18. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood. 1987;69: 1580-1586.
19. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III, Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
20. Huber S, McMaster KJ, Volkerding KV. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A. J Mol Diagn. 2000;2:153-157.
21. Lichy C, Reuner KH, Buggle F, Litfin F, Rickmann H, Kunze A, Brandt T, Grau A. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovasc Dis. 2003;16:83-87.
22. Rohr J, Kittner S, Feeser B, Hebel JR, Whyte MG, Weinstein A, Kanarak N, Buchholz D, Earley C, Johnson C, et al. Traditional risk factors and ischemic stroke in young adults: the Baltimore-Washington Cooperative Young Stroke Study. Arch Neurol. 1996;53:603-607.
23. De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, Servidei S, Tonali PA, Leone G. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood. 1998;91:3562-3565.
24. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation. 1999;99:999-1004.